Phase 1 Study Evaluating VT1021 in Patients With Advanced Solid Tumors
Clinical trial NCT03364400 · UNKNOWN
Trial details
- NCT number
- NCT03364400
- Sponsor
- Vigeo Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-28
- Primary completion
- 2024-01-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.